|
Dr. Remick is a consultant psychiatrist with the Department of Psychiatry, St. Paul's Hospital, Vancouver, BC.
Correspondence to: Dr. Ronald A. Remick, Department of Psychiatry, St. Paul's Hospital, 1081 Burrard St., Vancouver BC V6Z 1Y6; rremick{at}shaw.ca
Abstract
THERE HAS BEEN SIGNIFICANT PROGRESS in the area of mood disorders over the last 2 decades, encompassing advances in our knowledge of epidemiology, diagnosis, pathogenesis and treatment. This article presents a clinically oriented update and review on the diagnosis and management of major depressive disorder.
This article has been cited by other articles:
![]() |
L. C. Brown, S. R. Majumdar, S. C. Newman, and J. A. Johnson Type 2 diabetes does not increase risk of depression. Can. Med. Assoc. J., July 4, 2006; 175(1): 42 - 46. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Williams, R. E. Clouse, and P. J. Lustman Treating Depression to Prevent Diabetes and Its Complications: Understanding Depression as a Medical Risk Factor Clin. Diabetes, April 1, 2006; 24(2): 79 - 86. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Brown, S. R. Majumdar, S. C. Newman, and J. A. Johnson History of Depression Increases Risk of Type 2 Diabetes in Younger Adults Diabetes Care, May 1, 2005; 28(5): 1063 - 1067. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Choi Nefazodone (Serzone) withdrawn because of hepatotoxicity Can. Med. Assoc. J., November 25, 2003; 169(11): 1187 - 1187. [Full Text] [PDF] |
||||
![]() |
E. Wooltorton Paroxetine (Paxil, Seroxat): increased risk of suicide in pediatric patients Can. Med. Assoc. J., September 2, 2003; 169(5): 446 - 446. [Full Text] [PDF] |
||||